IP Forecast: Fed. Circ. To Mull Arthrex's Latest USPTO Fight
Arthrex will argue next week that the Federal Circuit must undo the Patent Trial and Appeal Board's invalidation of its suture patent because the patent office's interim leader lacks the power...To view the full article, register now.
Already a subscriber? Click here to view full article